ESC 365 - Influence of sacubitril/valsartan on hibernating myocardium in patients with chronic heart failure with reduced ejection fraction

ACNAP Premium Access

Influence of sacubitril/valsartan on hibernating myocardium in patients with chronic heart failure with reduced ejection fraction

Session: ePoster session 4

Topic: Treatment

Speaker: Doctor M. Mukhamedova (Tashkent, UZ)

Event: ACNAP-EuroHeartCare 2022

Congress Presentation

Add to my library

About the speaker

Doctor Muyassar Mukhamedova

CENTER FOR THE DEVELOPMENT OF PROFESSIONAL QUALIFICATION OF MEDICAL WORKERS, Tashkent (Uzbekistan)

0 follower

17 more presentations in this session

How do Heart Failure Caregivers gain information and support for their role? The contribution of specialist nurses.

Speaker: Doctor S. Schutz (Oxford, GB)

Non-introduction or withdrawal of prognostic-modifying drugs in HF with reduced ejection fraction

Speaker: Miss C. Maciel (Penafiel, PT)

Effectiveness of nurse-led self-care interventions on self-care behaviours, self-efficacy, depression, and illness perceptions in people with heart failure: a meta-analysis

Speaker: Mr Z. Huang (Hong Kong, CN)

Soluble ST2 and nutritional status in patients hospitalized with heart failure with reduced ejection fraction - pilot study

Speaker: Mr F. Wasniewski (Poznan, PL)

Depressive symptoms are mediating the relationship between non-cardiac comorbidities and self-care of heart failure

Speaker: Associate Professor K. Lee (Seoul, KR)

Access the full session

ePoster session 4

Speakers: Doctor M. Mukhamedova, Doctor S. Schutz, Miss C. Maciel, Mr Z. Huang, Mr F. Wasniewski...

About the event

ACNAP-EuroHeartCare 2022

22 May - 23 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources